Company News in the Life Science Industry

»

Reset 

Vir Biotechnology Announces Pricing of Public Offering of Common Stock

Read more ››
By: GlobenewsWire - 08 Jul 2020
Related companies:  Vir Biotechnology, Inc.

Kiadis licenses previously undisclosed pre-clinical K-NK-cell programs to Sanofi, with total potential deal value of €875 million, plus royalties

Read more ››
By: GlobenewsWire - 08 Jul 2020
Related companies:  Kiadis Pharma N.V.

Barclays and Unreasonable Select 1mg Technologies to Receive $100,000 Grant in Support of COVID-19 Related Work

NEW DELHI, July 8, 2020 /PRNewswire/ -- 1mg Technologies has been awarded a $100,000 grant in recognition of the exceptional work being undertaken in addressing the immediate and long term challenges resulting from the effects of the global pandemic.

Read more ››
By: PR Newswire Association LLC. - 08 Jul 2020

Akero Therapeutics Announces Pricing of Public Offering of Common Stock

SOUTH SAN FRANCISCO, Calif., July 7, 2020 /PRNewswire/ -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a cardio-metabolic non-alcoholic steatohepatitis (NASH) company developing pioneering medicines designed to restore metabolic balance and improve the overall health of NASH patients, announced today... Read more ››

By: PR Newswire Association LLC. - 08 Jul 2020
Related companies:  Akero Therapeutics, Inc.

Coronavirus (COVID-19) Update: Daily Roundup

SILVER SPRING, Md., July 7, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) today continued to take action in the ongoing response to the COVID-19 pandemic:

Read more ››
By: PR Newswire Association LLC. - 08 Jul 2020
Related companies:  U.S. Food and Drug Administration

Turning Point Therapeutics and Zai Lab Announce Exclusive License Agreement for Repotrectinib in Greater China

SHANGHAI, July 8, 2020 /PRNewswire/ -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation therapies that target genetic drivers of cancer, and Zai Lab (NASDAQ: ZLAB), an innovative commercial-stage biopharmaceutical company, today announced... Read more ››

By: PR Newswire Association LLC. - 08 Jul 2020

Rapidly Changing Behaviours In 2020 Are Accelerating Consumer Embrace of Digital, Health, and Sustainability Trends, Says PwC

NEW YORK, July 7, 2020 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 08 Jul 2020

60% Are Willing to Risk Their Health To Vote In Person In November

MOUNTAIN VIEW, Calif., July 8, 2020 /PRNewswire/ -- Sacrificing one's health to vote in the November election: 60% are willing to risk their health to vote in person, according to the latest Read more ››

By: PR Newswire Association LLC. - 08 Jul 2020

Lupin Pharmaceuticals, Inc. Issues Voluntarily Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets, 500mg and 1000mg Due to the Detection of  N-Nitrosodimethylamine (NDMA) Impurity

BALTIMORE, July 8, 2020 /PRNewswire/ -- Lupin Pharmaceuticals Inc. is voluntarily recalling all batches of Metformin Hydrochloride Extended-Release Tablets USP, 500mg and 1000mg to the consumer level. As part of the ongoing assessment and continuation of the dialog with the FDA, additional analysis... Read more ››

By: PR Newswire Association LLC. - 08 Jul 2020
Related companies:  Lupin Pharmaceuticals, Inc.

CENTOGENE Announces Proposed Primary and Secondary Public Offering of Common Shares

Read more ››
By: GlobenewsWire - 08 Jul 2020
Related companies:  Centogene N.V.

CooperRiis Launches New Insurance Driven Intensive Clinical Program

ASHEVILLE, N.C., July 7, 2020 /PRNewswire/ -- CooperRiis residential mental health treatment and healing community in Western North Carolina is pleased to introduce their new clinically intensive and insurance-driven CooperRiis at Asheville Program, opening September 1(st),... Read more ››

By: PR Newswire Association LLC. - 08 Jul 2020

Dr. Leslie Fish, of Chandler, Arizona, Becomes the World’s Most Experienced Dental Robotics Surgeon

Read more ››
By: GlobenewsWire - 07 Jul 2020
Related companies:  Neocis Inc.

Sienna Announces Second Quarter 2020 Results Release Date and Conference Call

Read more ››
By: GlobenewsWire - 07 Jul 2020

Sunesis Pharmaceuticals Provides Corporate Update

Read more ››
By: GlobenewsWire - 07 Jul 2020
Related companies:  Sunesis Pharmaceuticals, Inc.

Zomedica Pharmaceuticals Corp. Closes $30 Million Public Offering

Read more ››
By: GlobenewsWire - 07 Jul 2020
Related companies:  Zomedica Pharmaceuticals Corp.

Aclaris Therapeutics Submits Investigational New Drug Application for ATI-1777, a Topical “Soft” JAK1/3 Inhibitor, for the Treatment of Moderate to Severe Atopic Dermatitis

Read more ››
By: GlobenewsWire - 07 Jul 2020
Related companies:  Aclaris Therapeutics, Inc.

Satsuma Pharmaceuticals Announces the Appointment of Thomas M. Soloway to its Board of Directors

Read more ››
By: GlobenewsWire - 07 Jul 2020
Related companies:  Satsuma Pharmaceuticals, Inc.

AETERNA ZENTARIS ANNOUNCES CLOSING OF $12 MILLION PUBLIC OFFERING

Read more ››
By: GlobenewsWire - 07 Jul 2020
Related companies:  AEterna Zentaris Inc.

Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: GlobenewsWire - 07 Jul 2020
Related companies:  Apellis Pharmaceuticals, Inc.

GenMark Diagnostics Provides Preliminary Financial and Operational Results for Second Quarter 2020

Read more ››
By: GlobenewsWire - 07 Jul 2020
Related companies:  GenMark Diagnostics, Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15 16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies